Atomoxetine was FDA approved for ADHD in 2002 and touted as a true alternative to stimulants. While it remains popular today, many clinicians report less than stellar results in treating the core symptoms of ADHD. This recent review and meta-analysis by Schwartz and Correll examines all randomized controlled studies of atomoxetine versus placebo. While meta-analyses […]
Tags: adhd, atomoxetine, strattera